Showing results (1-10 of 35) with videos related to
Sort By:
Pageof 4
Angewandte Chemie (International Ed. in English)|September 13, 2014
Enzymatic polyketide chain branching to give substituted lactone, lactam, and glutarimide heterocyclesDaniel Heine, Tom Bretschneider, Srividhya Sundaram, et al.Chemical Communications (Cambridge, England)|May 22, 2015
Twofold polyketide branching by a stereoselective enzymatic Michael additionDaniel Heine, Srividhya Sundaram, Tom Bretschneider, et al.Nature Chemical Biology|December 20, 2011
A ketosynthase homolog uses malonyl units to form esters in cervimycin biosynthesisTom Bretschneider, Georg Zocher, Michelle Unger, et al.Drug Development and Industrial Pharmacy|March 13, 2020
A smart approach to enable preclinical studies in pharmaceutical industry: PLGA-based extended release formulation platform for subcutaneous applicationsPatrick Strack, Raimund Külzer, Florian Sommer, et al.European Journal of Immunology|September 1, 2018
FKBP51 modulates steroid sensitivity and NFκB signalling: A novel anti-inflammatory drug targetMarc Kästle, Barbara Kistler, Thorsten Lamla, et al.Angewandte Chemie (International Ed. in English)|November 20, 2012
Imaging mass spectrometry and genome mining reveal highly antifungal virulence factor of mushroom soft rot pathogenKatharina Graupner, Kirstin Scherlach, Tom Bretschneider, et al.SLAS Discovery : Advancing Life Sciences R & D|March 23, 2017
Ultrafast and Predictive Mass Spectrometry-Based Autotaxin Assays for Label-Free Potency ScreeningTom Bretschneider, Andreas Harald Luippold, Helmut Romig, et al.British Journal of Pharmacology|December 3, 2017
Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosisManuel Baader, Tom Bretschneider, Andre Broermann, et al.SLAS Technology|August 4, 2018
Automated MALDI Target Preparation Concept: Providing Ultra-High-Throughput Mass Spectrometry-Based Screening for Drug DiscoveryMartin Winter, Robert Ries, Carola Kleiner, et al.Scientific Reports|January 30, 2020
Biomarker discovery for chronic liver diseases by multi-omics - a preclinical case studyDaniel Veyel, Kathrin Wenger, Andre Broermann, et al.Pageof 4